Literature DB >> 15337617

Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center.

Jennifer A Galvin1, Gregory P Van Stavern.   

Abstract

BACKGROUND: Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri (PTC), is a condition characterized by increased intracranial pressure without clinical, laboratory or radiologic evidence of an intracranial space-occupying lesion, meningeal inflammation or venous outflow obstruction. Previous population-based studies evaluated the presenting clinical features of IIH in North-Eastern Libya, Iowa, Louisiana, Minnesota, Northern Ireland, Israel and Western Turkey. However, we report the demographic patterns of a metropolitan North American city.
METHODS: We performed a retrospective study of all patients with an initial IIH diagnosis and follow-up at the Detroit Medical Center (DMC), Michigan from 1985 to 2002. Medical records of 174 patients were reviewed, with 77 patients fitting the diagnostic criteria.
RESULTS: Seventy-seven patients, 71 females (92.2%) and 6 males (7.8%) were identified. Age ranged from 10 to 50 years, with a mean of 34 years. Fifty patients (65%) were African-American and 24 patients (31%) were Caucasian. The most common presentation was isolated headache (28.6%). Nineteen patients (24.7%) were asymptomatic. Obesity was described in 65 of 74 patients (87.8%) evaluated for body dimensions.
CONCLUSIONS: We report an increased number of asymptomatic patients after routine ophthalmic examination. Obese females in metropolitan Detroit would benefit from routine eye evaluations to avoid potential visual loss related to papilledema.

Entities:  

Mesh:

Year:  2004        PMID: 15337617     DOI: 10.1016/j.jns.2004.05.009

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Racial differences in idiopathic intracranial hypertension.

Authors:  B B Bruce; P Preechawat; N J Newman; M J Lynn; V Biousse
Journal:  Neurology       Date:  2008-03-11       Impact factor: 9.910

3.  Sonographic assessment of the optic nerve sheath in idiopathic intracranial hypertension.

Authors:  Jochen Bäuerle; Max Nedelmann
Journal:  J Neurol       Date:  2011-04-28       Impact factor: 4.849

4.  The incidence of idiopathic intracranial hypertension in Scotland: a SOSU study.

Authors:  Colin Goudie; Pushkar Shah; Justin McKee; Barny Foot; Obaid Kousha; Andrew Blaikie
Journal:  Eye (Lond)       Date:  2019-04-30       Impact factor: 3.775

5.  Enlargement of Dorello's Canal as a Novel Radiographic Marker of Idiopathic Intracranial Hypertension.

Authors:  Michael Eggerstedt; Sumeet G Dua; Antonios N Varelas; Sudeep H Bhabad; Pete S Batra; Bobby A Tajudeen
Journal:  J Neurol Surg B Skull Base       Date:  2019-05-03

Review 6.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

Review 7.  High-pressure headaches: idiopathic intracranial hypertension and its mimics.

Authors:  Kuan-Po Peng; Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

8.  Fulminant Idiopathic Intracranial Hypertension With Malignant Systemic Hypertension-A Case Report.

Authors:  Hina N Abbasi; Adrian J Brady; Sarah A Cooper
Journal:  Neuroophthalmology       Date:  2013-05-31

9.  Risk factors for idiopathic intracranial hypertension in men: a case-control study.

Authors:  J Alexander Fraser; Beau B Bruce; Janet Rucker; Lisa-Ann Fraser; Edward J Atkins; Nancy J Newman; Valérie Biousse
Journal:  J Neurol Sci       Date:  2009-11-30       Impact factor: 3.181

10.  Idiopathic intracranial hypertension in men.

Authors:  B B Bruce; S Kedar; G P Van Stavern; D Monaghan; M D Acierno; R A Braswell; P Preechawat; J J Corbett; N J Newman; V Biousse
Journal:  Neurology       Date:  2008-10-15       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.